TARDBP and amyotrophic lateral sclerosis: These gain-of-function mutations only account for about 10% of familial cases of ALS/FTLD, while 90% of affected individuals are sporadic cases involving wild-type TDP-43 mediated neurodegeneration (Nguyen et al., 2018).